Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
GO_Biological_Process_2021,Ribosome,68/158,1.6627925343453035e-51,4.206865111893618e-49,0,0,18.790380993770825,2197.034130169101,RPL5;RPL30;RPL3;RPL31;RPL34;RPLP1;MRPS12;MRPL36;RPL10A;MRPL34;RPL9;MRPL35;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPL18A;RPS19;RPL36AL;RPS18;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;MRPS21;RPL13A;RPSA;RPS3A;RPL24;RPL27;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPS4Y1;RPS3;RPL13;RPL15;RPS2;RPL18;RPS27A;RPL19;RPL41;MRPL27;RPL35A;RPL23A;RPS25;RPS27;RPL27A;RPS20;FAU;RPS21;RPS24;RPS23
GO_Biological_Process_2021,Coronavirus disease,62/232,7.77244338216966e-33,9.832140878444621e-31,0,0,8.961951145270527,662.5993798587735,RPL5;RPL30;RPL3;RPL31;RPL34;RPLP1;RPL10A;RPL9;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPL18A;RPS19;RPL36AL;RPS18;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPSA;RPS3A;RPL24;RPL27;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPS4Y1;RPS3;RPL13;RPL15;RPS2;RPL18;RPS27A;RPL19;RPL41;RPL35A;RPL23A;RPS25;RPS27;RPL27A;RPS20;FAU;RPS21;RPS24;RPS23
GO_Biological_Process_2021,Parkinson disease,42/249,9.18522933927439e-15,7.746210076121402e-13,0,0,4.850631430816748,156.77813017106743,NDUFB9;COX7B;NDUFA12;NDUFB11;COX4I1;NDUFB4;NDUFB3;NDUFB2;ATP5MC3;UQCR10;COX7C;COX7A1;UQCRH;GNAI2;PSMD8;PSMB6;PSMD7;PSMD3;CYC1;RPS27A;XBP1;ATP5PD;ATP5PB;NDUFA3;ADRM1;NDUFA2;NDUFA1;NDUFC1;COX6C;TUBB4B;ATP5F1E;COX6B1;PSMC5;NDUFS8;UQCRQ;NDUFS6;DDIT3;NDUFS5;SLC25A5;UBA52;SLC25A4;SLC25A6
GO_Biological_Process_2021,Oxidative phosphorylation,29/133,1.6212257270264526e-13,1.0254252723442312e-11,0,0,6.594400171788509,194.2078792657849,NDUFB9;COX7B;NDUFA12;NDUFB11;COX4I1;NDUFB4;COX17;NDUFB3;NDUFB2;ATP5MC3;UQCR10;COX7A1;COX7C;UQCRH;CYC1;ATP6V1F;ATP5PD;ATP5PB;NDUFA3;NDUFA2;NDUFA1;NDUFC1;COX6C;ATP5F1E;COX6B1;NDUFS8;UQCRQ;NDUFS6;NDUFS5
GO_Biological_Process_2021,Huntington disease,44/306,7.105384100546672e-13,3.595324354876616e-11,0,0,4.013337064880671,112.26408797977813,NDUFB9;COX7B;DCTN2;NDUFA12;NDUFB11;COX4I1;NDUFB4;DCTN3;NDUFB3;NDUFB2;ATP5MC3;UQCR10;COX7C;COX7A1;UQCRH;PSMD8;PSMB6;PSMD7;PSMD3;POLR2G;CYC1;POLR2I;POLR2J;POLR2L;ATP5PD;ATP5PB;NDUFA3;ADRM1;NDUFA2;NDUFA1;NDUFC1;ATG14;COX6C;TUBB4B;ATP5F1E;COX6B1;PSMC5;NDUFS8;UQCRQ;NDUFS6;NDUFS5;SLC25A5;SLC25A4;SLC25A6
GO_Biological_Process_2021,Prion disease,39/273,1.7915721630126228e-11,7.554462620703224e-10,0,0,3.9637772194304857,98.08502482986304,NDUFB9;COX7B;NDUFA12;NDUFB11;COX4I1;NDUFB4;NDUFB3;NDUFB2;ATP5MC3;UQCR10;COX7C;COX7A1;UQCRH;PSMD8;PSMB6;PSMD7;PSMD3;CYC1;ATP5PD;ATP5PB;NDUFA3;ADRM1;NDUFA2;NDUFA1;NDUFC1;COX6C;TUBB4B;ATP5F1E;COX6B1;GRIN3B;PSMC5;NDUFS8;UQCRQ;NDUFS6;DDIT3;NDUFS5;SLC25A5;SLC25A4;SLC25A6
GO_Biological_Process_2021,Diabetic cardiomyopathy,32/203,8.995580681907503e-11,3.251259875032284e-09,0,0,4.42644177900126,102.39113481488536,NDUFB9;COX7B;NDUFA12;NDUFB11;COX4I1;NDUFB4;NDUFB3;NDUFB2;ATP5MC3;UQCR10;COX7C;COX7A1;UQCRH;CYC1;ATP5PD;ATP5PB;NDUFA3;NDUFA2;NDUFA1;NDUFC1;COX6C;ATP5F1E;COX6B1;TGFBR2;NDUFS8;UQCRQ;NDUFS6;NDUFS5;SLC25A5;GAPDH;SLC25A4;SLC25A6
GO_Biological_Process_2021,Alzheimer disease,42/369,4.01102211987828e-09,1.268485745411506e-07,0,0,3.0511470782188184,58.99154805521431,NDUFB9;COX7B;NDUFA12;NDUFB11;COX4I1;NDUFB4;NDUFB3;NDUFB2;ATP5MC3;UQCR10;COX7C;COX7A1;UQCRH;PSMD8;PSMB6;PSMD7;PSMD3;CYC1;XBP1;ATP5PD;ATP5PB;NDUFA3;ADRM1;NDUFA2;NDUFA1;NDUFC1;ATG14;COX6C;TUBB4B;ATP5F1E;COX6B1;PSMC5;NDUFS8;UQCRQ;NDUFS6;DDIT3;NDUFS5;NOX4;SLC25A5;GAPDH;SLC25A4;SLC25A6
GO_Biological_Process_2021,Non-alcoholic fatty liver disease,25/155,6.336088512841082e-09,1.7811448819431044e-07,0,0,4.519230769230769,85.30953826894239,NDUFB9;COX7B;NDUFA12;NDUFB11;COX4I1;NDUFB4;NDUFB3;NDUFB2;UQCR10;COX7A1;COX7C;UQCRH;CYC1;XBP1;NDUFA3;NDUFA2;NDUFA1;NDUFC1;COX6C;COX6B1;NDUFS8;UQCRQ;NDUFS6;DDIT3;NDUFS5
GO_Biological_Process_2021,Amyotrophic lateral sclerosis,41/364,8.329864843389613e-09,2.107455805377572e-07,0,0,3.012227932403241,56.037737163733546,NDUFB9;COX7B;DCTN2;NDUFA12;NDUFB11;COX4I1;NDUFB4;DCTN3;NDUFB3;NDUFB2;ATP5MC3;UQCR10;COX7C;COX7A1;UQCRH;ACTG1;PSMD8;PSMB6;PSMD7;PSMD3;NEFL;CYC1;XBP1;ATP5PD;ATP5PB;NDUFA3;ADRM1;NDUFA2;NDUFA1;NDUFC1;ATG14;COX6C;TUBB4B;ATP5F1E;COX6B1;PSMC5;NDUFS8;UQCRQ;NDUFS6;DDIT3;NDUFS5
GO_Biological_Process_2021,Thermogenesis,31/232,1.0864107542820429e-08,2.4987447348486985e-07,0,0,3.637805994901116,66.70936374680163,NDUFB9;COX7B;NDUFA12;NDUFB11;COX4I1;NDUFB4;COX17;NDUFB3;NDUFB2;ATP5MC3;UQCR10;COX7C;COX7A1;UQCRH;ACTG1;CYC1;COA4;ATP5PD;ATP5PB;NDUFA3;RPS6;NDUFA2;NDUFA1;NDUFC1;COX6C;ATP5F1E;COX6B1;NDUFS8;UQCRQ;NDUFS6;NDUFS5
GO_Biological_Process_2021,Pathways of neurodegeneration,46/475,1.0972709387191903e-07,2.313412895799626e-06,0,0,2.546246318109436,40.80428350856798,NDUFB9;COX7B;DCTN2;NDUFA12;NDUFB11;COX4I1;NDUFB4;NDUFB3;DCTN3;NDUFB2;ATP5MC3;UQCR10;COX7C;COX7A1;UQCRH;PSMD8;PSMB6;PSMD7;PSMD3;NEFL;CYC1;RPS27A;XBP1;ATP5PD;ATP5PB;NDUFA3;ADRM1;NDUFA2;NDUFA1;NDUFC1;ATG14;TUBB4B;COX6C;ATP5F1E;COX6B1;PSMC5;NDUFS8;UQCRQ;NDUFS6;DDIT3;NDUFS5;NOX4;SLC25A5;UBA52;SLC25A4;SLC25A6
GO_Biological_Process_2021,Cardiac muscle contraction,12/87,0.0002582836077721903,0.0050265963666433,0,0,3.711300121506683,30.660729005903523,SLC8A3;COX7B;UQCRQ;COX4I1;CACNA2D4;UQCR10;CYC1;COX6C;COX7C;COX7A1;UQCRH;COX6B1
GO_Biological_Process_2021,Proteasome,8/46,0.0005688357391080292,0.0102796744281665,0,0,4.869089289123656,36.38144003677314,PSMB6;PSMD8;PSMC5;PSMD7;PSMD3;ADRM1;PSME1;PSMB8
GO_Biological_Process_2021,Retrograde endocannabinoid signaling,15/148,0.0013567600071468,0.0228840187872103,0,0,2.617641665138456,17.28338684209198,NDUFB9;NDUFA12;NDUFB11;NDUFB4;NDUFA3;NDUFB3;NDUFA2;NDUFB2;NDUFA1;NDUFC1;GNAI2;RIMS1;NDUFS8;NDUFS6;NDUFS5
GO_Biological_Process_2021,RNA polymerase,6/31,0.0015641357112721,0.024732895934491,0,0,5.541133896260555,35.7980626008538,POLR2G;POLR3H;POLR2I;POLR2J;POLR3K;POLR2L
GO_Biological_Process_2021,Protein export,5/23,0.0022515489152046,0.033508345620398,0,0,6.407965194109773,39.06383302792055,SRP54;SEC61B;SRP14;SEC62;SEC11C
GO_Biological_Process_2021,Spliceosome,14/150,0.0041264459069309,0.0579994896918628,0,0,2.385953285089919,13.099691890681294,SF3B5;SF3A1;SF3B6;LSM2;LSM7;PHF5A;ZMAT2;PRPF3;PPIE;SNRNP27;DHX38;DHX16;SNRNP200;RBM22
GO_Biological_Process_2021,Spinocerebellar ataxia,12/143,0.0167789436292479,0.22342488095788,0,0,2.118557131329246,8.659878818217816,PSMD8;PSMB6;XBP1;GRIN3B;PSMC5;PSMD7;PSMD3;ADRM1;ATG14;SLC25A5;SLC25A4;SLC25A6
GO_Biological_Process_2021,Viral myocarditis,6/60,0.038567637998517,0.48788062068124,0,0,2.561452888352768,8.338404522940806,SGCB;HLA-C;HLA-A;HLA-F;ACTG1;HLA-E
GO_Biological_Process_2021,Base excision repair,4/33,0.0472882447627869,0.5697107583326233,0,0,3.1762313788953898,9.69224953256553,PCNA;MPG;PARP2;APEX1
GO_Biological_Process_2021,Vibrio cholerae infection,5/50,0.0566525464700287,0.651504284405331,0,0,2.5595716198125835,7.348065152774091,ARF1;SEC61B;CFTR;ACTG1;ATP6V1F
GO_Biological_Process_2021,Allograft rejection,4/38,0.0726351247563688,0.7989863723200576,0,0,2.7084306646846463,7.102335775782995,HLA-C;HLA-A;HLA-F;HLA-E
GO_Biological_Process_2021,HIF-1 signaling pathway,8/109,0.0858248321023098,0.9047367717451829,0,0,1.8259006069893569,4.4834019776901295,LDHA;PFKL;IFNGR2;RPS6;ELOB;TIMP1;GAPDH;RBX1
GO_Biological_Process_2021,Graft-versus-host disease,4/42,0.0969546416457321,0.93465443355164,0,0,2.4228260181138768,5.653693639860362,HLA-C;HLA-A;HLA-F;HLA-E
GO_Biological_Process_2021,Metabolism of xenobiotics by cytochrome P450,6/76,0.097554725142949,0.93465443355164,0,0,1.9743236257108392,4.594925851331484,GSTM4;CBR1;ADH4;GSTP1;ADH5;CBR3
GO_Biological_Process_2021,Type I diabetes mellitus,4/43,0.1035605906128055,0.93465443355164,0,0,2.360578851553581,5.352844876469704,HLA-C;HLA-A;HLA-F;HLA-E
GO_Biological_Process_2021,Mineral absorption,5/60,0.1048669138070118,0.93465443355164,0,0,2.0930996714129244,4.7200720854642855,SLC8A3;MT2A;FTH1;FTL;MT1E
GO_Biological_Process_2021,Antigen processing and presentation,6/78,0.1071343026600694,0.93465443355164,0,0,1.9192802573381584,4.287042698666386,PSME1;HLA-C;HLA-A;HLA-F;B2M;HLA-E
GO_Biological_Process_2021,Pentose phosphate pathway,3/30,0.1283029090562234,0.9999958051203856,0,0,2.555822649572649,5.248027404574654,PFKL;GLYCTK;TALDO1
GO_Biological_Process_2021,Necroptosis,10/159,0.1293486480293997,0.9999958051203856,0,0,1.546959528167582,3.163909418547495,STAT5A;H2AZ1;FTH1;H2AC20;IFNGR2;CHMP2A;SLC25A5;SLC25A4;FTL;SLC25A6
GO_Biological_Process_2021,Glycolysis / Gluconeogenesis,5/67,0.1475202784583693,0.9999958051203856,0,0,1.8561018266614848,3.5521884310181604,ADH4;LDHA;PFKL;GAPDH;ADH5
GO_Biological_Process_2021,Retinol metabolism,5/68,0.1541417562822773,0.9999958051203856,0,0,1.8265442723274048,3.415423361402583,ADH4;CYP3A7-CYP3A51P;RETSAT;ALDH1A2;ADH5
GO_Biological_Process_2021,Nicotinate and nicotinamide metabolism,3/35,0.1784384852927312,0.9999958051203856,0,0,2.1559119591346154,3.715738747050604,QPRT;NMNAT3;NUDT12
GO_Biological_Process_2021,Autoimmune thyroid disease,4/53,0.1795541297132339,0.9999958051203856,0,0,1.877845723126796,3.2247841959752264,HLA-C;HLA-A;HLA-F;HLA-E
GO_Biological_Process_2021,DNA replication,3/36,0.189041802244036,0.9999958051203856,0,0,2.090472027972028,3.4822813632039,PCNA;MCM4;MCM2
GO_Biological_Process_2021,Tyrosine metabolism,3/36,0.189041802244036,0.9999958051203856,0,0,2.090472027972028,3.4822813632039,ADH4;TYRP1;ADH5
GO_Biological_Process_2021,Human T-cell leukemia virus 1 infection,12/219,0.2060409618857772,0.9999958051203856,0,0,1.335376054378643,2.1094672273030546,STAT5A;HLA-C;TSPO;HLA-A;HLA-F;TLN1;SLC25A5;B2M;SLC25A4;HLA-E;TGFBR2;SLC25A6
GO_Biological_Process_2021,Arrhythmogenic right ventricular cardiomyopathy,5/77,0.218674181604145,0.9999958051203856,0,0,1.5974732262382865,2.4284347277628666,SLC8A3;JUP;SGCB;CACNA2D4;ACTG1
GO_Biological_Process_2021,Epstein-Barr virus infection,11/202,0.2247442824400032,0.9999958051203856,0,0,1.3261449702638133,1.979658662919664,PSMD8;PSMC5;PSMD7;PSMD3;ADRM1;HLA-C;HLA-A;HLA-F;B2M;CD44;HLA-E
GO_Biological_Process_2021,RNA degradation,5/79,0.2340310815449932,0.9999958051203856,0,0,1.5541354607619668,2.2570730204893845,BTG3;LSM7;PFKL;BTG1;LSM2
GO_Biological_Process_2021,Ferroptosis,3/41,0.2440993793104062,0.9999958051203856,0,0,1.814935475708502,2.5593854266474376,GPX4;FTH1;FTL
GO_Biological_Process_2021,Peroxisome,5/82,0.257601769061146,0.9999958051203856,0,0,1.4933500234705055,2.025490994012125,PRDX5;EHHADH;PRDX1;MPV17L2;NUDT12
GO_Biological_Process_2021,Cell cycle,7/124,0.2610131829389343,0.9999958051203856,0,0,1.3763574053429126,1.8487017455684844,CDKN1C;PCNA;MCM4;PKMYT1;BUB1;RBX1;MCM2
GO_Biological_Process_2021,Fatty acid degradation,3/43,0.2668075269008225,0.9999958051203856,0,0,1.7240084134615383,2.277807763247387,ADH4;EHHADH;ADH5
GO_Biological_Process_2021,Protein processing in endoplasmic reticulum,9/171,0.2862255780362242,0.9999958051203856,0,0,1.2781140704869518,1.5988888064046682,XBP1;UBXN1;SELENOS;DDIT3;EIF2AK1;RAD23A;SEC61B;SEC62;RBX1
GO_Biological_Process_2021,Riboflavin metabolism,1/8,0.2891067016110682,0.9999958051203856,0,0,3.281603288797533,4.072336610034634,BLVRB
GO_Biological_Process_2021,Sulfur relay system,1/8,0.2891067016110682,0.9999958051203856,0,0,3.281603288797533,4.072336610034634,TST
GO_Biological_Process_2021,Drug metabolism,6/108,0.2965169513627911,0.9999958051203856,0,0,1.3526573476193855,1.6443591093569472,GSTM4;ADH4;NME7;GSTP1;FMO4;ADH5
GO_Biological_Process_2021,Phagosome,8/152,0.3024213784352788,0.9999958051203856,0,0,1.2777777777777777,1.5281378138727746,HLA-C;HLA-A;SEC61B;HLA-F;TUBB4B;ACTG1;HLA-E;ATP6V1F
GO_Biological_Process_2021,Nucleotide excision repair,3/47,0.3128182152971638,0.9999958051203856,0,0,1.5669525786713288,1.8210073621563605,PCNA;RAD23A;RBX1
GO_Biological_Process_2021,Pyruvate metabolism,3/47,0.3128182152971638,0.9999958051203856,0,0,1.5669525786713288,1.8210073621563605,ADH4;LDHA;ADH5
GO_Biological_Process_2021,Hypertrophic cardiomyopathy,5/90,0.3227331790021857,0.9999958051203856,0,0,1.3522324592487598,1.5292794009937742,SLC8A3;SGCB;CACNA2D4;ACTG1;TTN
GO_Biological_Process_2021,Cellular senescence,8/156,0.3272727613498854,0.9999958051203856,0,0,1.2429817967907448,1.3883625924713991,HLA-C;HLA-A;HLA-F;SLC25A5;SLC25A4;HLA-E;TGFBR2;SLC25A6
GO_Biological_Process_2021,Cocaine addiction,3/49,0.335931640600565,0.9999958051203856,0,0,1.498667433110368,1.6348177580865697,GRIN3B;RGS9;GNAI2
GO_Biological_Process_2021,Sulfur metabolism,1/10,0.3472512578105091,0.9999958051203856,0,0,2.552091660005329,2.6993643843816537,TST
GO_Biological_Process_2021,Cysteine and methionine metabolism,3/50,0.3474774790167651,0.9999958051203856,0,0,1.4667041734860884,1.5503876029583137,LDHA;TST;APIP
GO_Biological_Process_2021,Dilated cardiomyopathy,5/96,0.3727124176954012,0.9999958051203856,0,0,1.2626770819541904,1.2461968162008883,SLC8A3;SGCB;CACNA2D4;ACTG1;TTN
GO_Biological_Process_2021,Circadian rhythm,2/31,0.3734137743055832,0.9999958051203856,0,0,1.584302686591878,1.560646131858421,BHLHE41;RBX1
GO_Biological_Process_2021,Galactose metabolism,2/31,0.3734137743055832,0.9999958051203856,0,0,1.584302686591878,1.560646131858421,PFKL;GALK1
GO_Biological_Process_2021,Gastric acid secretion,4/76,0.3923196714286514,0.9999958051203856,0,0,1.2764407006284262,1.194337843349207,KCNK10;CFTR;ACTG1;GNAI2
GO_Biological_Process_2021,Fanconi anemia pathway,3/54,0.3933642553363218,0.9999958051203856,0,0,1.3513857466063348,1.260868899568,CENPX;RMI1;USP1
GO_Biological_Process_2021,Progesterone-mediated oocyte maturation,5/100,0.406080291551186,0.9999958051203856,0,0,1.2092580849714647,1.089788678483982,SPDYE17;SPDYE3;PKMYT1;BUB1;GNAI2
GO_Biological_Process_2021,Propanoate metabolism,2/34,0.4180525770572716,0.9999958051203856,0,0,1.4355492196878752,1.2520114841166556,LDHA;EHHADH
GO_Biological_Process_2021,Glutathione metabolism,3/57,0.4272296560371681,0.9999958051203856,0,0,1.2761084401709402,1.0852454618195622,GSTM4;GPX4;GSTP1
GO_Biological_Process_2021,Oocyte meiosis,6/129,0.4530123869725416,0.9999958051203856,0,0,1.1204801553443762,0.8872363109060601,SPDYE17;SPDYE3;FBXO43;PKMYT1;BUB1;RBX1
GO_Biological_Process_2021,Purine metabolism,6/129,0.4530123869725416,0.9999958051203856,0,0,1.1204801553443762,0.8872363109060601,ENTPD2;NME7;NPR2;PDE4A;ADPRM;HDDC3
GO_Biological_Process_2021,"Alanine, aspartate and glutamate metabolism",2/37,0.4610200389408875,0.9999958051203856,0,0,1.3122963471102729,1.0161291299352266,CPS1;NIT2
GO_Biological_Process_2021,Glycerolipid metabolism,3/61,0.4712785768908477,0.9999958051203856,0,0,1.1878522877984086,0.8936282861512934,GLYCTK;GPAT3;LCLAT1
GO_Biological_Process_2021,Cytosolic DNA-sensing pathway,3/63,0.4927223360522844,0.9999958051203856,0,0,1.1481370192307692,0.8126622625079899,POLR3H;POLR3K;POLR2L
GO_Biological_Process_2021,Nitrogen metabolism,1/17,0.5158143155812719,0.9999958051203856,0,0,1.4350269784172662,0.9499999595555698,CPS1
GO_Biological_Process_2021,Selenocompound metabolism,1/17,0.5158143155812719,0.9999958051203856,0,0,1.4350269784172662,0.9499999595555698,PSTK
GO_Biological_Process_2021,Neutrophil extracellular trap formation,8/189,0.5349609452129639,0.9999958051203856,0,0,1.014597126002926,0.6346929348921975,H2AZ1;H2AC20;AQP9;SLC25A5;H4C3;SLC25A4;ACTG1;SLC25A6
GO_Biological_Process_2021,Other glycan degradation,1/18,0.5360462160479709,0.9999958051203856,0,0,1.350543094935816,0.8421107504839455,FUCA2
GO_Biological_Process_2021,Mitophagy,3/68,0.5443377448801309,0.9999958051203856,0,0,1.0595414201183433,0.644397590855543,TOMM7;RPS27A;UBA52
GO_Biological_Process_2021,TGF-beta signaling pathway,4/94,0.555993000322357,0.9999958051203856,0,0,1.020189864955208,0.5988510162901164,ID3;RBX1;TGFBR2;BMP5
GO_Biological_Process_2021,One carbon pool by folate,1/20,0.5740119280981002,0.9999958051203856,0,0,1.208254449072321,0.6707082094597879,TYMS
GO_Biological_Process_2021,Shigellosis,10/246,0.5796646997820354,0.9999958051203856,0,0,0.9722136620441704,0.5301534050084747,RRAGA;ARF1;ATG14;TLN1;RPS27A;UBA52;MYL12A;CD44;ACTG1;RBX1
GO_Biological_Process_2021,Cell adhesion molecules,6/148,0.5872176653271478,0.9999958051203856,0,0,0.969588338232046,0.5161697744436841,MPZ;HLA-C;MADCAM1;HLA-A;HLA-F;HLA-E
GO_Biological_Process_2021,Glycerophospholipid metabolism,4/98,0.5891484771072433,0.9999958051203856,0,0,0.9765727014363622,0.516682197857802,GPAT3;ADPRM;CDIPT;LCLAT1
GO_Biological_Process_2021,Salmonella infection,10/249,0.5951060869699157,0.9999958051203856,0,0,0.9598579941676176,0.4981812649839805,ARF1;DCTN2;DCTN3;RHOG;RPS3;BRK1;TUBB4B;GAPDH;MYL12A;ACTG1
GO_Biological_Process_2021,Amino sugar and nucleotide sugar metabolism,2/48,0.6011766528372008,0.9999958051203856,0,0,0.9979122083616055,0.507804048994686,CYB5R3;GALK1
GO_Biological_Process_2021,AGE-RAGE signaling pathway in diabetic complications,4/100,0.6051709031359037,0.9999958051203856,0,0,0.9561271560369032,0.4802094871667342,STAT5A;COL4A4;NOX4;TGFBR2
GO_Biological_Process_2021,Arginine biosynthesis,1/22,0.6088742794450481,0.9999958051203856,0,0,1.0930684024209203,0.5423187504264798,CPS1
GO_Biological_Process_2021,Endocytosis,10/252,0.6102787459732991,0.9999958051203856,0,0,0.9478086651640372,0.4680653246743499,ARF1;CHMP2A;HLA-C;VPS35;HLA-A;HLA-F;VPS25;EPN1;HLA-E;TGFBR2
GO_Biological_Process_2021,Mannose type O-glycan biosynthesis,1/23,0.6252217077349919,0.9999958051203856,0,0,1.0433289731850883,0.4899983669567856,RXYLT1
GO_Biological_Process_2021,Mismatch repair,1/23,0.6252217077349919,0.9999958051203856,0,0,1.0433289731850883,0.4899983669567856,PCNA
GO_Biological_Process_2021,Renin-angiotensin system,1/23,0.6252217077349919,0.9999958051203856,0,0,1.0433289731850883,0.4899983669567856,ATP6AP2
GO_Biological_Process_2021,Synaptic vesicle cycle,3/78,0.6377318544470254,0.9999958051203856,0,0,0.9177884615384616,0.4128555521782533,RIMS1;SLC6A12;ATP6V1F
GO_Biological_Process_2021,Vitamin digestion and absorption,1/24,0.6408866626347826,0.9999958051203856,0,0,0.9979147117088938,0.4439749007681346,TCN2
GO_Biological_Process_2021,Natural killer cell mediated cytotoxicity,5/131,0.6433520216248243,0.9999958051203856,0,0,0.9102600879709314,0.401482260926451,VAV3;IFNGR2;HLA-C;HLA-A;HLA-E
GO_Biological_Process_2021,Glycosaminoglycan biosynthesis,2/53,0.6551625379955573,0.9999958051203856,0,0,0.8998422898571193,0.3805180408757963,XYLT2;B3GALT6
GO_Biological_Process_2021,Th17 cell differentiation,4/107,0.6581528280622241,0.9999958051203856,0,0,0.8908205110230977,0.3726463553110032,STAT5A;IRF4;IFNGR2;TGFBR2
GO_Biological_Process_2021,Human immunodeficiency virus 1 infection,8/212,0.6643382520023087,0.9999958051203856,0,0,0.8991156317424188,0.367705784551187,HLA-C;ELOB;HLA-A;HLA-F;B2M;HLA-E;GNAI2;RBX1
GO_Biological_Process_2021,Folate biosynthesis,1/26,0.6702818034688581,0.9999958051203856,0,0,0.9179856115107914,0.3672466182842049,CBR1
GO_Biological_Process_2021,Biosynthesis of unsaturated fatty acids,1/27,0.6840654009644865,0.9999958051203856,0,0,0.8826323556539384,0.3351370504767609,ACOT2
GO_Biological_Process_2021,Collecting duct acid secretion,1/27,0.6840654009644865,0.9999958051203856,0,0,0.8826323556539384,0.3351370504767609,ATP6V1F
GO_Biological_Process_2021,Fatty acid elongation,1/27,0.6840654009644865,0.9999958051203856,0,0,0.8826323556539384,0.3351370504767609,ACOT2
GO_Biological_Process_2021,Pyrimidine metabolism,2/56,0.6846569404767961,0.9999958051203856,0,0,0.8497176648437152,0.3219048164320942,NME7;TYMS
GO_Biological_Process_2021,Complement and coagulation cascades,3/85,0.6946409620081536,0.9999958051203856,0,0,0.8391328564727955,0.3057465888347833,F8;SERPING1;CLU
GO_Biological_Process_2021,Butanoate metabolism,1/28,0.6972734445797607,0.9999958051203856,0,0,0.8498978594901856,0.3064541548014284,EHHADH
GO_Biological_Process_2021,Phototransduction,1/28,0.6972734445797607,0.9999958051203856,0,0,0.8498978594901856,0.3064541548014284,RGS9
GO_Biological_Process_2021,Kaposi sarcoma-associated herpesvirus infection,7/193,0.7001111632332122,0.9999958051203856,0,0,0.862637005869825,0.3075440258433812,HLA-C;HLA-A;ATG14;HLA-F;RPS27A;UBA52;HLA-E
GO_Biological_Process_2021,cGMP-PKG signaling pathway,6/167,0.7022094045588705,0.9999958051203856,0,0,0.8543107388232474,0.3020190269975828,SLC8A3;NPR2;SLC25A5;SLC25A4;SLC25A6;GNAI2
GO_Biological_Process_2021,Leukocyte transendothelial migration,4/114,0.7061225522648177,0.9999958051203856,0,0,0.833825620829231,0.2901433576887074,VAV3;MYL12A;ACTG1;GNAI2
GO_Biological_Process_2021,ECM-receptor interaction,3/88,0.7168685470208758,0.9999958051203856,0,0,0.8093891402714932,0.2694155295949914,COL4A4;COL9A3;CD44
GO_Biological_Process_2021,Gap junction,3/88,0.7168685470208758,0.9999958051203856,0,0,0.8093891402714932,0.2694155295949914,PDGFD;TUBB4B;GNAI2
GO_Biological_Process_2021,Long-term depression,2/60,0.7207278246165,0.9999958051203856,0,0,0.7909508631038622,0.2590314326106079,PPP1R17;GNAI2
GO_Biological_Process_2021,Citrate cycle (TCA cycle),1/30,0.7220578919812009,0.9999958051203856,0,0,0.7912015215413876,0.2576547442409206,IDH3B
GO_Biological_Process_2021,Glyoxylate and dicarboxylate metabolism,1/30,0.7220578919812009,0.9999958051203856,0,0,0.7912015215413876,0.2576547442409206,GLYCTK
GO_Biological_Process_2021,beta-Alanine metabolism,1/30,0.7220578919812009,0.9999958051203856,0,0,0.7912015215413876,0.2576547442409206,EHHADH
GO_Biological_Process_2021,Arachidonic acid metabolism,2/61,0.7291837212155267,0.9999958051203856,0,0,0.7775042220277941,0.2455588168048984,CBR1;CBR3
GO_Biological_Process_2021,Focal adhesion,7/201,0.7390307701378831,0.9999958051203856,0,0,0.8267157228945664,0.2500118317041096,VAV3;PDGFD;COL4A4;COL9A3;TLN1;MYL12A;ACTG1
GO_Biological_Process_2021,Viral carcinogenesis,7/203,0.7481864358051078,0.9999958051203856,0,0,0.8181935817805382,0.2373604832944006,STAT5A;MRPS18B;HLA-C;HLA-A;HLA-F;H4C3;HLA-E
GO_Biological_Process_2021,Fructose and mannose metabolism,1/33,0.7554864043395564,0.9999958051203856,0,0,0.7169139688249401,0.2010180119071604,PFKL
GO_Biological_Process_2021,SNARE interactions in vesicular transport,1/33,0.7554864043395564,0.9999958051203856,0,0,0.7169139688249401,0.2010180119071604,VAMP5
GO_Biological_Process_2021,Platelet activation,4/124,0.7658646585809776,0.9999958051203856,0,0,0.7639390292819895,0.2037805915068687,TLN1;MYL12A;ACTG1;GNAI2
GO_Biological_Process_2021,Aminoacyl-tRNA biosynthesis,2/66,0.7682603182177616,0.9999958051203856,0,0,0.7165741296518607,0.1889080353093354,NARS1;PSTK
GO_Biological_Process_2021,Acute myeloid leukemia,2/67,0.7754603821999349,0.9999958051203856,0,0,0.7055129744205374,0.1794108096060009,STAT5A;JUP
GO_Biological_Process_2021,Mucin type O-glycan biosynthesis,1/36,0.7848986228926578,0.9999958051203856,0,0,0.6553614251455978,0.1587290040178141,C1GALT1C1L
GO_Biological_Process_2021,Hematopoietic cell lineage,3/99,0.7876929563938654,0.9999958051203856,0,0,0.7162334735576923,0.1709269083855028,IL7;CD9;CD44
GO_Biological_Process_2021,Renal cell carcinoma,2/69,0.7892752578995886,0.9999958051203856,0,0,0.6843812151726362,0.161952073175605,ELOB;RBX1
GO_Biological_Process_2021,RNA transport,6/186,0.793472208141448,0.9999958051203856,0,0,0.7633695215118617,0.1765954348622121,UPF2;EIF5B;PHAX;EIF2S2;EIF2B1;EIF1B
GO_Biological_Process_2021,Central carbon metabolism in cancer,2/70,0.7958977380671424,0.9999958051203856,0,0,0.6742814772968011,0.1539280578828631,LDHA;PFKL
GO_Biological_Process_2021,Adherens junction,2/71,0.802335389184141,0.9999958051203856,0,0,0.6644744854463525,0.1463362640903761,ACTG1;TGFBR2
GO_Biological_Process_2021,Chagas disease,3/102,0.8042527855903837,0.9999958051203856,0,0,0.6944201631701632,0.1512736336391982,IFNGR2;TGFBR2;GNAI2
GO_Biological_Process_2021,Protein digestion and absorption,3/103,0.80952602824994,0.9999958051203856,0,0,0.6874399038461538,0.1452604189139002,SLC8A3;COL4A4;COL9A3
GO_Biological_Process_2021,"Glycine, serine and threonine metabolism",1/40,0.818692025343932,0.9999958051203856,0,0,0.5880218901801636,0.1176321934001313,GLYCTK
GO_Biological_Process_2021,Nicotine addiction,1/40,0.818692025343932,0.9999958051203856,0,0,0.5880218901801636,0.1176321934001313,GRIN3B
GO_Biological_Process_2021,PPAR signaling pathway,2/74,0.8205780352592187,0.9999958051203856,0,0,0.636688008536748,0.1259026763054021,EHHADH;DBI
GO_Biological_Process_2021,"Parathyroid hormone synthesis, secretion and action",3/106,0.8246302135179252,0.9999958051203856,0,0,0.667312359970127,0.1286713155040581,NACA;PDE4A;GNAI2
GO_Biological_Process_2021,Chronic myeloid leukemia,2/76,0.83188642370302,0.9999958051203856,0,0,0.619415333701048,0.1140091883166798,STAT5A;TGFBR2
GO_Biological_Process_2021,Pertussis,2/76,0.83188642370302,0.9999958051203856,0,0,0.619415333701048,0.1140091883166798,SERPING1;GNAI2
GO_Biological_Process_2021,Tryptophan metabolism,1/42,0.8335445121871498,0.9999958051203856,0,0,0.5592794057436977,0.1018269803124879,EHHADH
GO_Biological_Process_2021,Ribosome biogenesis in eukaryotes,3/108,0.834121458594967,0.9999958051203856,0,0,0.654532967032967,0.1187167373003478,SBDS;NOP10;REXO5
GO_Biological_Process_2021,Pathogenic Escherichia coli infection,6/197,0.8355644396505435,0.9999958051203856,0,0,0.7189890046040458,0.1291647978411244,ARF1;RPS3;BRK1;TUBB4B;GAPDH;ACTG1
GO_Biological_Process_2021,Bacterial invasion of epithelial cells,2/77,0.8372960829174352,0.9999958051203856,0,0,0.611124449779912,0.108521969100462,RHOG;ACTG1
GO_Biological_Process_2021,Porphyrin and chlorophyll metabolism,1/43,0.8405085842170756,0.9999958051203856,0,0,0.5459346808267671,0.0948551205924595,BLVRB
GO_Biological_Process_2021,Ubiquitin mediated proteolysis,4/140,0.8411680868361285,0.9999958051203856,0,0,0.6734975578679125,0.1164906790776846,ELOB;RPS27A;UBA52;RBX1
GO_Biological_Process_2021,Vasopressin-regulated water reabsorption,1/44,0.8471816280322604,0.9999958051203856,0,0,0.5332106407896938,0.0884277435513325,DCTN2
GO_Biological_Process_2021,Apoptosis,4/142,0.8489776832162855,0.9999958051203856,0,0,0.6636669631489911,0.1086571340575828,ENDOG;PARP2;DDIT3;ACTG1
GO_Biological_Process_2021,Influenza A,5/172,0.8497054827561034,0.9999958051203856,0,0,0.6853040906139528,0.1116123799480556,IFNGR2;SLC25A5;SLC25A4;ACTG1;SLC25A6
GO_Biological_Process_2021,ABC transporters,1/45,0.8535757915032884,0.9999958051203856,0,0,0.5210649662088511,0.0824954951815331,CFTR
GO_Biological_Process_2021,Basal transcription factors,1/45,0.8535757915032884,0.9999958051203856,0,0,0.5210649662088511,0.0824954951815331,GTF2F1
GO_Biological_Process_2021,B cell receptor signaling pathway,2/81,0.8573921580479656,0.9999958051203856,0,0,0.5800598720500859,0.0892479371208612,VAV3;CD81
GO_Biological_Process_2021,Other types of O-glycan biosynthesis,1/47,0.8655735586116828,0.9999958051203856,0,0,0.4983578354707538,0.0719443914597518,C1GALT1C1L
GO_Biological_Process_2021,Intestinal immune network for IgA production,1/48,0.8711990093234535,0.9999958051203856,0,0,0.4877289657635593,0.067250432604521,MADCAM1
GO_Biological_Process_2021,"Valine, leucine and isoleucine degradation",1/48,0.8711990093234535,0.9999958051203856,0,0,0.4877289657635593,0.067250432604521,EHHADH
GO_Biological_Process_2021,Rap1 signaling pathway,6/210,0.8761043046665665,0.9999958051203856,0,0,0.6727098559568581,0.0889794173280329,VAV3;EFNA1;PDGFD;TLN1;GNAI2;ACTG1
GO_Biological_Process_2021,Sphingolipid metabolism,1/49,0.8765893136297547,0.9999958051203856,0,0,0.477542965627498,0.0629003748373181,DEGS1
GO_Biological_Process_2021,Cholesterol metabolism,1/50,0.8817542893842795,0.9999958051203856,0,0,0.4677727205990309,0.0588653823184791,TSPO
GO_Biological_Process_2021,Malaria,1/50,0.8817542893842795,0.9999958051203856,0,0,0.4677727205990309,0.0588653823184791,CD81
GO_Biological_Process_2021,N-Glycan biosynthesis,1/50,0.8817542893842795,0.9999958051203856,0,0,0.4677727205990309,0.0588653823184791,ALG10B
GO_Biological_Process_2021,Ovarian steroidogenesis,1/51,0.8867033451560611,0.9999958051203856,0,0,0.4583932853717026,0.0551194089266935,ACOT2
GO_Biological_Process_2021,Herpes simplex virus 1 infection,16/498,0.8885653096544281,0.9999958051203856,0,0,0.7572436784055041,0.0894661662305866,ZNF100;ZNF154;ZNF671;ZNF492;EIF2AK1;IFNGR2;HLA-C;HLA-A;HLA-F;HLA-E;ZNF528;ZNF726;EIF2B1;ZNF585B;B2M;ZFP28
GO_Biological_Process_2021,Oxytocin signaling pathway,4/154,0.8892955781311837,0.9999958051203856,0,0,0.6101885278780586,0.0715907442331135,NPR2;CACNA2D4;ACTG1;GNAI2
GO_Biological_Process_2021,GABAergic synapse,2/89,0.8909297624270103,0.9999958051203856,0,0,0.5265002552745236,0.0608053484586592,SLC6A12;GNAI2
GO_Biological_Process_2021,Alcoholism,5/186,0.8923356241498557,0.9999958051203856,0,0,0.6318311921720029,0.0719737593699145,H2AZ1;GRIN3B;H2AC20;H4C3;GNAI2
GO_Biological_Process_2021,Bile secretion,2/90,0.8945650353706359,0.9999958051203856,0,0,0.5204900141874932,0.0579917861171932,AQP9;CFTR
GO_Biological_Process_2021,Endocrine and other factor-regulated calcium reabsorption,1/53,0.895989384662905,0.9999958051203856,0,0,0.4407166574432761,0.0484024620945404,SLC8A3
GO_Biological_Process_2021,Morphine addiction,2/91,0.8980873510844288,0.9999958051203856,0,0,0.5146148346979241,0.0553148897555412,PDE4A;GNAI2
GO_Biological_Process_2021,Th1 and Th2 cell differentiation,2/92,0.9014997907245424,0.9999958051203856,0,0,0.5088702147525677,0.0527675353143752,STAT5A;IFNGR2
GO_Biological_Process_2021,Regulation of lipolysis in adipocytes,1/55,0.904515141629328,0.9999958051203856,0,0,0.4243494093613997,0.0425861086049515,GNAI2
GO_Biological_Process_2021,Lysosome,3/128,0.9069926368316634,0.9999958051203856,0,0,0.5492307692307692,0.0536164278450886,CD63;FUCA2;ARSG
GO_Biological_Process_2021,Relaxin signaling pathway,3/129,0.90973129918921,0.9999958051203856,0,0,0.5448431776556777,0.0515454329515061,COL4A4;TGFBR2;GNAI2
GO_Biological_Process_2021,Human cytomegalovirus infection,6/225,0.9121262686928732,0.9999958051203856,0,0,0.6261381099525754,0.0575902084996601,HLA-C;HLA-A;HLA-F;B2M;HLA-E;GNAI2
GO_Biological_Process_2021,Legionellosis,1/57,0.9123427943821576,0.9999958051203856,0,0,0.4091512504282288,0.0375353264320131,ARF1
GO_Biological_Process_2021,Hippo signaling pathway,4/163,0.9130320597673438,0.9999958051203856,0,0,0.5753770935979232,0.0523502730365937,AFP;ACTG1;BMP5;TGFBR2
GO_Biological_Process_2021,Prostate cancer,2/97,0.9170174658697762,0.9999958051203856,0,0,0.4819612055348455,0.0417517016792715,PDGFD;GSTP1
GO_Biological_Process_2021,Notch signaling pathway,1/59,0.9195294418994338,0.9999958051203856,0,0,0.3950012403870007,0.0331379243736901,DTX3L
GO_Biological_Process_2021,Choline metabolism in cancer,2/98,0.919831971564788,0.9999958051203856,0,0,0.4769157663065226,0.039853115584757,SLC22A4;PDGFD
GO_Biological_Process_2021,mRNA surveillance pathway,2/98,0.919831971564788,0.9999958051203856,0,0,0.4769157663065226,0.039853115584757,UPF2;CSTF2T
GO_Biological_Process_2021,Hepatocellular carcinoma,4/168,0.9241613503124028,0.9999958051203856,0,0,0.5576883566669601,0.0439841005037206,GSTM4;GSTP1;ACTG1;TGFBR2
GO_Biological_Process_2021,Systemic lupus erythematosus,3/135,0.92467978826428,0.9999958051203856,0,0,0.5199136800699301,0.0407132841290016,H2AZ1;H2AC20;H4C3
GO_Biological_Process_2021,Steroid hormone biosynthesis,1/61,0.9261275181737976,0.9999958051203856,0,0,0.3817945643485211,0.0293001920495368,CYP3A7-CYP3A51P
GO_Biological_Process_2021,Tight junction,4/169,0.926227382656032,0.9999958051203856,0,0,0.5542792546402655,0.0424774793785276,PCNA;CFTR;MYL12A;ACTG1
GO_Biological_Process_2021,Melanogenesis,2/101,0.927745815017251,0.9999958051203856,0,0,0.4623910170128658,0.034678165649779,TYRP1;GNAI2
GO_Biological_Process_2021,Apelin signaling pathway,3/137,0.9291354491830364,0.9999958051203856,0,0,0.512099956946039,0.037639730776369,SLC8A3;RPS6;GNAI2
GO_Biological_Process_2021,Autophagy,3/137,0.9291354491830364,0.9999958051203856,0,0,0.512099956946039,0.037639730776369,RRAGA;ATG16L2;ATG14
GO_Biological_Process_2021,Yersinia infection,3/137,0.9291354491830364,0.9999958051203856,0,0,0.512099956946039,0.037639730776369,VAV3;RHOG;ACTG1
GO_Biological_Process_2021,Amoebiasis,2/102,0.930215664927971,0.9999958051203856,0,0,0.4577430972388955,0.0331125964086125,COL4A4;PRDX1
GO_Biological_Process_2021,Lysine degradation,1/63,0.9321851726756072,0.9999958051203856,0,0,0.3694399319254274,0.0259434762251826,EHHADH
GO_Biological_Process_2021,Proteoglycans in cancer,5/205,0.9332627767195372,0.9999958051203856,0,0,0.5712349397590362,0.039454323708946,VAV3;CD63;RPS6;CD44;ACTG1
GO_Biological_Process_2021,Fluid shear stress and atherosclerosis,3/139,0.933347757601854,0.9999958051203856,0,0,0.5045160492081447,0.03480021392605,GSTM4;GSTP1;ACTG1
GO_Biological_Process_2021,Measles,3/139,0.933347757601854,0.9999958051203856,0,0,0.5045160492081447,0.03480021392605,STAT5A;EIF2AK1;RACK1
GO_Biological_Process_2021,Chemical carcinogenesis,6/239,0.9371740212959638,0.9999958051203856,0,0,0.5880811981962859,0.0381584084755831,GSTM4;STAT5A;CBR1;CYP3A7-CYP3A51P;GSTP1;GNAI2
GO_Biological_Process_2021,Inflammatory bowel disease,1/65,0.9377466202243236,0.9999958051203856,0,0,0.357857464028777,0.0230014653391465,IFNGR2
GO_Biological_Process_2021,Glucagon signaling pathway,2/107,0.9414117892575627,0.9999958051203856,0,0,0.4358314754473217,0.0263131627569668,LDHA;PFKL
GO_Biological_Process_2021,Fc epsilon RI signaling pathway,1/68,0.9452463043180536,0.9999958051203856,0,0,0.3417803070976055,0.0192455622664419,VAV3
GO_Biological_Process_2021,Amphetamine addiction,1/69,0.947539981868426,0.9999958051203856,0,0,0.3367364931584144,0.0181454317305583,GRIN3B
GO_Biological_Process_2021,Renin secretion,1/69,0.947539981868426,0.9999958051203856,0,0,0.3367364931584144,0.0181454317305583,GNAI2
GO_Biological_Process_2021,Axon guidance,4/182,0.9488269409726222,0.9999958051203856,0,0,0.5134466393542368,0.0269707647651881,EFNA1;SEMA3E;MYL12A;GNAI2
GO_Biological_Process_2021,Epithelial cell signaling in Helicobacter pylori infection,1/70,0.949737681320734,0.9999958051203856,0,0,0.3318388767247072,0.017112750831055,ATP6V1F
GO_Biological_Process_2021,Prolactin signaling pathway,1/70,0.949737681320734,0.9999958051203856,0,0,0.3318388767247072,0.017112750831055,STAT5A
GO_Biological_Process_2021,cAMP signaling pathway,5/216,0.950007635058132,0.9999958051203856,0,0,0.5411408667846742,0.0277525487057808,VAV3;GRIN3B;PDE4A;CFTR;GNAI2
GO_Biological_Process_2021,Toxoplasmosis,2/112,0.9508870291826766,0.9999958051203856,0,0,0.4159118192731638,0.0209453254984684,IFNGR2;GNAI2
GO_Biological_Process_2021,Regulation of actin cytoskeleton,5/218,0.952607166055048,0.9999958051203856,0,0,0.5360031675999773,0.0260243838520466,VAV3;PDGFD;BRK1;MYL12A;ACTG1
GO_Biological_Process_2021,Adrenergic signaling in cardiomyocytes,3/150,0.9526621979757712,0.9999958051203856,0,0,0.4664933281004709,0.0226225472454267,SLC8A3;CACNA2D4;GNAI2
GO_Biological_Process_2021,Melanoma,1/72,0.9538610246389276,0.9999958051203856,0,0,0.3224575269361975,0.015232021203873,PDGFD
GO_Biological_Process_2021,Non-small cell lung cancer,1/72,0.9538610246389276,0.9999958051203856,0,0,0.3224575269361975,0.015232021203873,STAT5A
GO_Biological_Process_2021,Glutamatergic synapse,2/114,0.9542517264062288,0.9999958051203856,0,0,0.4084419482078545,0.0191264289510656,GRIN3B;GNAI2
GO_Biological_Process_2021,Inositol phosphate metabolism,1/73,0.9557941961634958,0.9999958051203856,0,0,0.3179622968292033,0.0143759228363686,CDIPT
GO_Biological_Process_2021,mTOR signaling pathway,3/154,0.9582851742691508,0.9999958051203856,0,0,0.4540403718797758,0.0193466005930902,RRAGA;RPS6;ATP6V1F
GO_Biological_Process_2021,Thyroid hormone synthesis,1/75,0.9594211940251408,0.9999958051203856,0,0,0.3093363147319982,0.0128142875368749,DUOX1
GO_Biological_Process_2021,Pancreatic cancer,1/76,0.9611216439974796,0.9999958051203856,0,0,0.3051958433253397,0.0121023267303505,TGFBR2
GO_Biological_Process_2021,"Growth hormone synthesis, secretion and action",2/119,0.961725849377231,0.9999958051203856,0,0,0.3908845589517858,0.015254601691316,STAT5A;GNAI2
GO_Biological_Process_2021,Sphingolipid signaling pathway,2/119,0.961725849377231,0.9999958051203856,0,0,0.3908845589517858,0.015254601691316,DEGS1;GNAI2
GO_Biological_Process_2021,Leishmaniasis,1/77,0.9627509141018322,0.9999958051203856,0,0,0.3011643316925407,0.0114323657247683,IFNGR2
GO_Biological_Process_2021,AMPK signaling pathway,2/120,0.9630730781154286,0.9999958051203856,0,0,0.3875516308218202,0.0145820115262481,PFKL;CFTR
GO_Biological_Process_2021,Thyroid hormone signaling pathway,2/121,0.9643747026122836,0.9999958051203856,0,0,0.3842747182906776,0.0139397053735577,PFKL;ACTG1
GO_Biological_Process_2021,Hepatitis B,3/162,0.9677032579533278,0.9999958051203856,0,0,0.4310141509433962,0.0141501042363044,STAT5A;PCNA;TGFBR2
GO_Biological_Process_2021,JAK-STAT signaling pathway,3/162,0.9677032579533278,0.9999958051203856,0,0,0.4310141509433962,0.0141501042363044,STAT5A;IL7;IFNGR2
GO_Biological_Process_2021,Osteoclast differentiation,2/127,0.9713052961093088,0.9999958051203856,0,0,0.3657142857142857,0.0106475688191343,IFNGR2;TGFBR2
GO_Biological_Process_2021,Wnt signaling pathway,3/166,0.971622181464664,0.9999958051203856,0,0,0.4203486314299198,0.0121011024483454,SFRP1;RSPO4;RBX1
GO_Biological_Process_2021,ErbB signaling pathway,1/85,0.973554895450972,0.9999958051203856,0,0,0.2723678200296905,0.0072997479153303,STAT5A
GO_Biological_Process_2021,Calcium signaling pathway,5/240,0.974086886349652,0.9999958051203856,0,0,0.48526018969495,0.0127403964274327,SLC8A3;PDGFD;SLC25A5;SLC25A4;SLC25A6
GO_Biological_Process_2021,Colorectal cancer,1/86,0.974663593189272,0.9999958051203856,0,0,0.2691493863732543,0.0069071538274271,TGFBR2
GO_Biological_Process_2021,Taste transduction,1/86,0.974663593189272,0.9999958051203856,0,0,0.2691493863732543,0.0069071538274271,ENTPD2
GO_Biological_Process_2021,PD-L1 expression and PD-1 checkpoint pathway in cancer,1/89,0.9777187776961992,0.9999958051203856,0,0,0.2599329627207325,0.0058571210886132,IFNGR2
GO_Biological_Process_2021,Small cell lung cancer,1/92,0.9804059026645472,0.9999958051203856,0,0,0.2513242153529923,0.0049733560459332,COL4A4
GO_Biological_Process_2021,Rheumatoid arthritis,1/93,0.9812276354584692,0.9999958051203856,0,0,0.2485793973516838,0.0047107789491207,ATP6V1F
GO_Biological_Process_2021,NOD-like receptor signaling pathway,3/181,0.982663248940782,0.9999958051203856,0,0,0.3846221369922212,0.0067265766903332,NLRP1;GBP2;GBP3
GO_Biological_Process_2021,Circadian entrainment,1/97,0.9841844065541008,0.9999958051203856,0,0,0.2381719624300559,0.0037969361040053,GNAI2
GO_Biological_Process_2021,Fc gamma R-mediated phagocytosis,1/97,0.9841844065541008,0.9999958051203856,0,0,0.2381719624300559,0.0037969361040053,VAV3
GO_Biological_Process_2021,Phosphatidylinositol signaling system,1/97,0.9841844065541008,0.9999958051203856,0,0,0.2381719624300559,0.0037969361040053,CDIPT
GO_Biological_Process_2021,MAPK signaling pathway,6/294,0.985044891452244,0.9999958051203856,0,0,0.4743918375552875,0.007148166460317,EFNA1;DDIT3;PDGFD;STMN1;CACNA2D4;TGFBR2
GO_Biological_Process_2021,Human papillomavirus infection,7/331,0.9862368066454892,0.9999958051203856,0,0,0.4916167173614839,0.0068132099968979,COL4A4;HLA-C;COL9A3;HLA-A;HLA-F;HLA-E;ATP6V1F
GO_Biological_Process_2021,Phospholipase D signaling pathway,2/148,0.986709045265843,0.9999958051203856,0,0,0.3127662023713595,0.0041848336724715,ARF1;PDGFD
GO_Biological_Process_2021,Gastric cancer,2/149,0.9871928370310918,0.9999958051203856,0,0,0.3106222080669002,0.0040038835156997,JUP;TGFBR2
GO_Biological_Process_2021,Pancreatic secretion,1/102,0.98723486891608,0.9999958051203856,0,0,0.2263219127668162,0.0029076267387229,CFTR
GO_Biological_Process_2021,Transcriptional misregulation in cancer,3/192,0.9880056369300578,0.9999958051203856,0,0,0.362026862026862,0.0043685332005247,JUP;DDIT3;TGFBR2
GO_Biological_Process_2021,T cell receptor signaling pathway,1/104,0.9882835604765982,0.9999958051203856,0,0,0.2219040301739191,0.0026152761059327,VAV3
GO_Biological_Process_2021,Hepatitis C,2/157,0.9904921219979164,0.9999958051203856,0,0,0.2944661735662007,0.0028131432591063,CD81;EIF2AK1
GO_Biological_Process_2021,Cholinergic synapse,1/113,0.992034272236471,0.9999958051203856,0,0,0.2039761048304214,0.0016313241238164,GNAI2
GO_Biological_Process_2021,Serotonergic synapse,1/113,0.992034272236471,0.9999958051203856,0,0,0.2039761048304214,0.0016313241238164,GNAI2
GO_Biological_Process_2021,PI3K-Akt signaling pathway,7/354,0.9925993576272564,0.9999958051203856,0,0,0.4584708126244274,0.0034055959226742,EFNA1;IL7;CDC37;PDGFD;COL4A4;RPS6;COL9A3
GO_Biological_Process_2021,Neurotrophin signaling pathway,1/119,0.9938414100075462,0.9999958051203856,0,0,0.1935434703084989,0.0011956403995725,BEX3
GO_Biological_Process_2021,Lipid and atherosclerosis,3/215,0.9945392753704864,0.9999958051203856,0,0,0.3223591708998549,0.0017651385301208,VAV3;XBP1;DDIT3
GO_Biological_Process_2021,Cytokine-cytokine receptor interaction,5/295,0.9948699085532576,0.9999958051203856,0,0,0.392085583714167,0.0020166120356012,IL26;IL7;IFNGR2;BMP5;TGFBR2
GO_Biological_Process_2021,FoxO signaling pathway,1/131,0.9963192667383738,0.9999958051203856,0,0,0.1755672385168788,0.0006474083754931195,TGFBR2
GO_Biological_Process_2021,Dopaminergic synapse,1/132,0.9964738337742404,0.9999958051203856,0,0,0.1742178776063119,0.0006154068481434333,GNAI2
GO_Biological_Process_2021,Vascular smooth muscle contraction,1/133,0.9966219122382126,0.9999958051203856,0,0,0.1728889615580263,0.0005850227715926782,NPR2
GO_Biological_Process_2021,Estrogen signaling pathway,1/137,0.9971546132571728,0.9999958051203856,0,0,0.1677687261955141,0.00047804734716102486,GNAI2
GO_Biological_Process_2021,Insulin signaling pathway,1/137,0.9971546132571728,0.9999958051203856,0,0,0.1677687261955141,0.00047804734716102486,RPS6
GO_Biological_Process_2021,Chemokine signaling pathway,2/192,0.9974742297283092,0.9999958051203856,0,0,0.2397801225753459,0.0006063956361621645,VAV3;GNAI2
GO_Biological_Process_2021,Pathways in cancer,11/531,0.99749346935997,0.9999958051203856,0,0,0.4786571135175504,0.0012012748669571,GSTM4;STAT5A;JUP;IL7;IFNGR2;GSTP1;COL4A4;ELOB;RBX1;GNAI2;TGFBR2
GO_Biological_Process_2021,Signaling pathways regulating pluripotency of stem cells,1/143,0.9978003972062964,0.9999958051203856,0,0,0.1606292430844057,0.0003537096850130828,ID3
GO_Biological_Process_2021,Cushing syndrome,1/155,0.998685444653132,0.9999958051203856,0,0,0.1480192469401102,0.0001947074974526642,GNAI2
GO_Biological_Process_2021,Neuroactive ligand-receptor interaction,5/341,0.9987940732137892,0.9999958051203856,0,0,0.3375824727481354,0.0004073454102081969,GRIN3B;P2RY14;GLP2R;TSPO;UTS2
GO_Biological_Process_2021,Ras signaling pathway,2/232,0.999462233164428,0.9999958051203856,0,0,0.1976616733649981,0.00010632448405306476,EFNA1;PDGFD
GO_Biological_Process_2021,Tuberculosis,1/180,0.9995494927082748,0.9999958051203856,0,0,0.1271787039642029,5.730784325813989e-05,IFNGR2
GO_Biological_Process_2021,MicroRNAs in cancer,3/310,0.9998192958658274,0.9999958051203856,0,0,0.2214905412177399,4.002787318818674e-05,EFNA1;STMN1;CD44
GO_Biological_Process_2021,Olfactory transduction,2/440,0.9999958051203856,0.9999958051203856,0,0,0.1026547605343507,4.306252654915773e-07,SLC8A3;OR4N2
